NUS Links:
Chemotherapy-associated adverse events can result in early termination of cancer treatment. In this article, A/Prof Franco-Obregon demonstrates the sensitivity of breast cancer cells to combinational therapy of chemotherapy and pulsed electromagnetic field therapy. The potential value of this unique combination merits future investigation into new therapeutic strategies for breast cancer treatment.
Read more: https://doi.org/10.3389/fonc.2021.783803
This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …
Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …
Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …